UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Receptor and secreted targets of Wnt-I/beta-catenin signalling in mouse mammary epithelial cells

Kenny, PA; Enver, T; Ashworth, A; (2005) Receptor and secreted targets of Wnt-I/beta-catenin signalling in mouse mammary epithelial cells. BMC Cancer , 5 , Article 3. 10.1186/1471-2407-5-3. Green open access

[thumbnail of 1471-2407-5-3.pdf]
Preview
PDF
1471-2407-5-3.pdf

Download (751kB)

Abstract

Background: Deregulation of the Wnt/ beta-catenin signal transduction pathway has been implicated in the pathogenesis of tumours in the mammary gland, colon and other tissues. Mutations in components of this pathway result in beta-catenin stabilization and accumulation, and the aberrant modulation of beta-catenin/TCF target genes. Such alterations in the cellular transcriptional profile are believed to underlie the pathogenesis of these cancers. We have sought to identify novel target genes of this pathway in mouse mammary epithelial cells.Methods: Gene expression microarray analysis of mouse mammary epithelial cells inducibly expressing a constitutively active mutant of beta-catenin was used to identify target genes of this pathway.Results: The differential expression in response to DeltaNbeta-catenin for five putative target genes, Autotaxin, Extracellular Matrix Protein 1 (Ecm1), CD14, Hypoxia-inducible gene 2 (Hig2) and Receptor Activity Modifying Protein 3 (RAMP3), was independently validated by northern blotting. Each of these genes encodes either a receptor or a secreted protein, modulation of which may underlie the interactions between Wnt/beta-catenin tumour cells and between the tumour and its microenvironment. One of these genes, Hig2, previously shown to be induced by both hypoxia and glucose deprivation in human cervical carcinoma cells, was strongly repressed upon DeltaNbeta-catenin induction. The predicted N-terminus of Hig2 contains a putative signal peptide suggesting it might be secreted. Consistent with this, a Hig2-EGFP fusion protein was able to enter the secretory pathway and was detected in conditioned medium. Mutation of critical residues in the putative signal sequence abolished its secretion. The expression of human HIG2 was examined in a panel of human tumours and was found to be significantly downregulated in kidney tumours compared to normal adjacent tissue.Conclusions: HIG2 represents a novel non-cell autonomous target of the Wnt pathway which is potentially involved in human cancer.

Type: Article
Title: Receptor and secreted targets of Wnt-I/beta-catenin signalling in mouse mammary epithelial cells
Open access status: An open access version is available from UCL Discovery
DOI: 10.1186/1471-2407-5-3
Publisher version: http://dx.doi.org/10.1186/1471-2407-5-3
Language: English
Additional information: © 2005 Kenny et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: MOTILITY-STIMULATING PROTEIN, GREEN FLUORESCENT PROTEIN, BETA-CATENIN, GENE-EXPRESSION, LYSOPHOSPHOLIPASE-D, AUTOCRINE GROWTH, COLON-CARCINOMA, CYCLIN D1, PATHWAY, IDENTIFICATION
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Cancer Bio
URI: https://discovery.ucl.ac.uk/id/eprint/1336596
Downloads since deposit
79Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item